; and stage 5 (dialysis therapy): any status on continued dialysis therapy.
Both the occurrence of albuminuria and reduction in eGFR are independent risk factors for CVD [2] [3] [4] , although their clinical characteristics are somewhat different. It is accepted worldwide that albuminuria is very important biomarker of incipient diabetic nephropathy [5] . On the other hand, decline in eGFR is not useful as a diagnostic marker of incipient diabetic nephropathy [6] . Severely decreased eGFR is reported to predict renal failure or CVD regardless of the presence or absence of albuminuria [3] ; therefore, it is useful as a marker of the progression of diabetic nephropathy.
Although diabetic nephropathy is classified into five stages in "Classification of Diabetic Nephropathy 2014" [1] , it does not always proceed from one stage to the next orderly; there is a group of diabetic patients whose eGFR declines without the occurrence of albuminuria [7, 8] .
In this issue of Endocrinology and Metabolism, Lee et al. [9] reported that nonalbuminuric stage ≥3 CKD group (<60 mL/ min/1.73 m 2 ) was a significant category of diabetic nephropathy, and that the patients belonging to this category showed higher prevalence of CVD and retinopathy than those with preserved eGFR (≥60 mL/min/1.73 m 2 ). Because this group had shorter diabetic duration than the albuminuric stage ≥3 CKD group, nonalbuminuric stage probably proceed to albuminuric stage. Since the rate of treatment with angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers of the nonalbuminuric CKD group is higher than that of the albuminuric CKD group, by treating with renin-angiotensin system antagonists, regression from albuminuric CKD to nonalbuminuric CKD might be expected. According to the KNHANES (Korea National Health and Nutritional Examination Survey), 8.6% of diabetic patients belonged to the category of CKD defined as eGFR <60 mL/ min/1.73 m 2 [10] . This proportion seemed quite low compared Tanaka M, et al.
with the 39% reported in this paper [9] . This discrepancy might indicate that the subjects of this retrospective study did not represent the patients observed in the real clinical settings. Although the findings of Lee et al. [9] are worthwhile from a viewpoint of early detection and intervention of the patients at high risk, a prospective study with a larger number of patients is needed to confirm and establish the significance of nonalbuminuric renal insufficiency.
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